Browsing by Author Liu, YanRong
Showing results 1 to 4 of 4
Issue Date | Title | Author(s) |
2011 | Characteristics of BCR-ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients | Qin, YaZhen; Chen, ShanShan; Jiang, Bin; Jiang, Qian; Jiang, Hao; Li, JinLan; Li, LingDi; Lai, YueYun; Liu, YanRong; Huang, XiaoJun |
2009 | Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease | Qin, YaZhen; Zhu, HongHu; Jiang, Bin; Li, JinLan; Lu, XiJing; Li, LingDi; Ruan, GuoRui; Liu, YanRong; Chen, ShanShan; Huang, XiaoJun |
2006 | A limited antibody combination can monitor minimal residual disease for the patients with B-ALL having no details immunophenotyping data at diagnosis: A childgood and adult study | Liu, YanRong; Chang, Yan; Zhang, LePing; Cheng, YiFei; Li, LingDi; Hao, Le; Chen, ShanShan; Hong, XiaoJun; Lu, DaoPei; Li, GuiLan |
2009 | Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up | Qin, YaZhen; Jiang, Bin; Jiang, Qian; Jiang, Hao; Li, JinLan; Zhang, Yan; Zhu, HongHu; Li, LingDi; Chen, ShanShan; Liu, YanRong; Huang, XiaoJun |